Section Arrow
CRL.NYSE
- Charles River Laboratories International
Quotes are at least 15-min delayed:2025/11/08 12:21 EST
Regular Hours
Last
 168.05
-2.83 (-1.66%)
Day High 
171.5 
Prev. Close
170.88 
1-M High
199.66 
Volume 
900.95K 
Bid
150.38
Ask
193.37
Day Low
165.74 
Open
168.91 
1-M Low
160.01 
Market Cap 
8.41B 
Currency USD 
P/E 706.8 
%Yield -- 
10-SMA 181.49 
20-SMA 179.86 
50-SMA 167.86 
52-W High 222.1 
52-W Low 91.8609 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-1.53/10.25
Enterprise Value
11.13B
Balance Sheet
Book Value Per Share
69.19
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
2.27B
Operating Revenue Per Share
85.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHCSotera Health Company15.68-0.33-2.06%77.15PE
NEOGNeogen Corp6.4+0.42+7.02%879PE
OPKOPKO Health1.34-0.04-2.90%-- 
DHRDanaher Corp209.94-0.73-0.35%43.47PE
EXASExact Sciences Corp66.18-1.04-1.55%-- 
Quotes are at least 15-min delayed:2025/11/08 12:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.